• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200.

作者信息

Parodi Maurizio Battaglia, Cascavilla Marialucia, Papayannis Alexandros, Kontadakis Dimitrios Stelios, Bandello Francesco, Iacono Pierluigi

出版信息

Arch Ophthalmol. 2012 Jul;130(7):934-5. doi: 10.1001/archophthalmol.2011.2617.

DOI:10.1001/archophthalmol.2011.2617
PMID:22776937
Abstract
摘要

相似文献

1
Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200.玻璃体内注射贝伐单抗治疗视力低于20/200的晚期新生血管性年龄相关性黄斑变性
Arch Ophthalmol. 2012 Jul;130(7):934-5. doi: 10.1001/archophthalmol.2011.2617.
2
Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.基于新生血管性年龄相关性黄斑变性初始稳定后视力变化的抗血管内皮生长因子治疗的再治疗：3 年随访结果。
Retina. 2012 Sep;32(8):1471-9. doi: 10.1097/IAE.0b013e318236e805.
3
Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.用于治疗新生血管性年龄相关性黄斑变性的贝伐单抗持续给药方案：基线特征的重要性
Retina. 2014 May;34(5):846-52. doi: 10.1097/IAE.0000000000000033.
4
Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections.基于连续 3 个月每月注射 1 次后的个体化注射策略，玻璃体内注射贝伐单抗治疗新生血管性年龄相关性黄斑变性 12 个月的疗效。
Acta Ophthalmol. 2011 Nov;89(7):647-53. doi: 10.1111/j.1755-3768.2009.01740.x. Epub 2009 Oct 23.
5
Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact.贝伐单抗治疗新生血管性年龄相关性黄斑变性的治疗和延长方案：临床和经济影响。
Am J Ophthalmol. 2012 Mar;153(3):468-473.e1. doi: 10.1016/j.ajo.2011.08.011. Epub 2011 Oct 11.
6
Bevacizumab for neovascular age-related macular degeneration in China.贝伐单抗治疗中国新生血管性年龄相关性黄斑变性。
Ophthalmology. 2012 Oct;119(10):2087-93. doi: 10.1016/j.ophtha.2012.05.016. Epub 2012 Jul 20.
7
Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration.抗血管内皮生长因子药物的临床应用及新生血管性年龄相关性黄斑变性的疾病监测。
Am J Ophthalmol. 2014 Apr;157(4):825-833.e1. doi: 10.1016/j.ajo.2013.12.018. Epub 2013 Dec 31.
8
Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.纤维血管性色素上皮脱离是新生血管性年龄相关性黄斑变性长期视力衰退的一个危险因素。
Retina. 2014 Sep;34(9):1767-73. doi: 10.1097/IAE.0000000000000188.
9
Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab.系统使用β受体阻滞剂可能会减少湿性年龄相关性黄斑变性患者接受贝伐单抗治疗时重复玻璃体内注射的需求。
Retina. 2013 Mar;33(3):508-12. doi: 10.1097/IAE.0b013e3182695ba0.
10
A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.一项前瞻性、观察性、开放标签、多中心研究，旨在调查雷珠单抗在新生血管性年龄相关性黄斑变性患者中的日常治疗实践。
Acta Ophthalmol. 2015 Mar;93(2):126-33. doi: 10.1111/aos.12610. Epub 2014 Dec 9.

引用本文的文献

1
A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes.一项关于玻璃体内血管内皮生长因子抑制剂对心肾结局影响的系统评价和荟萃分析。
Nephrol Dial Transplant. 2023 Jun 30;38(7):1666-1681. doi: 10.1093/ndt/gfac305.
2
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.抗血管内皮生长因子用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2019 Mar 4;3(3):CD005139. doi: 10.1002/14651858.CD005139.pub4.
3
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
抗血管内皮生长因子用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2014 Aug 29;8(8):CD005139. doi: 10.1002/14651858.CD005139.pub3.
4
Management of significant reactivation of old disciform scars in wet age-related macular degeneration.湿性年龄相关性黄斑变性中陈旧盘状瘢痕的显著再激活的处理。
BMC Ophthalmol. 2014 Jun 25;14:82. doi: 10.1186/1471-2415-14-82.